Page last updated: 2024-08-23

pirfenidone and panobinostat

pirfenidone has been researched along with panobinostat in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bach, AC; Chillappagari, S; Fink, L; Guenther, A; Klepetko, W; Korfei, M; Krämer, OH; Lasky, JA; MacKenzie, B; Mahavadi, P; Pullamsetti, SS; Ruppert, C; Saito, S; Seeger, W; Skwarna, S; Stelmaszek, D	1

Other Studies

1 other study(ies) available for pirfenidone and panobinostat

Article	Year
Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis. PloS one, 2018, Volume: 13, Issue:11 Topics: Apoptosis; Cell Proliferation; Cell Survival; Down-Regulation; Endoplasmic Reticulum Stress; Extracellular Matrix Proteins; Female; Fibroblasts; Histone Deacetylase Inhibitors; Histones; Humans; Idiopathic Pulmonary Fibrosis; Lung; Male; Middle Aged; Panobinostat; Primary Cell Culture; Protective Agents; Pyridones; STAT3 Transcription Factor	2018

Article

Year

Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis.

PloS one, 2018, Volume: 13, Issue:11

Topics: Apoptosis; Cell Proliferation; Cell Survival; Down-Regulation; Endoplasmic Reticulum Stress; Extracellular Matrix Proteins; Female; Fibroblasts; Histone Deacetylase Inhibitors; Histones; Humans; Idiopathic Pulmonary Fibrosis; Lung; Male; Middle Aged; Panobinostat; Primary Cell Culture; Protective Agents; Pyridones; STAT3 Transcription Factor

2018